Bristol-Myers Squibb Co vs Rush Street Interactive Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.95 (market cap $129.94B), while Rush Street Interactive Inc trades at $24.24 (market cap $2.91B). The key difference: Bristol-Myers Squibb Co is far larger — about 44.7× Rush Street Interactive Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals.
| BMY | RSI | |
|---|---|---|
Market Cap | $129.94B | $2.91B |
Sector | Health | Technology |
52-Week High | $65.89 | $34.52 |
52-Week Low | $42.60 | $15.89 |
Enterprise Value | $163.92B | $2.57B |
Dividend Yield | 3.96% | — |
Signals from Pluang's Aura AI — not financial advice
Bristol Myers Squibb (BMY) trades at $63.88, down 1.48% on the day, with strong technical momentum indicated by bullish moving averages and ADX signals. The company demonstrates robust fundamentals with a 14.01 P/E ratio, 18.87% net income margin, and consistent earnings beats in recent quarters. Recent developments include a $2.3 billion manufacturing investment in Houston and strategic AI collaboration with Schrödinger.
BMY presents a compelling investment case with attractive valuation metrics and strong profitability, though investors face risks from patent expirations and debt levels. Analyst consensus suggests 7% upside to the $68.56 price target, with the stock offering dividend income alongside growth potential from pipeline developments and potential M&A activity.
Rush Street Interactive (RSI) trades at $24.53, down 0.77% on the day, amid mixed technical signals with a bearish overall trend but oversold oscillators. The company reported strong Q2 2026 results with record revenue of $393.8 million and raised full-year guidance, though net margins remain thin at 2.33%. Analyst sentiment remains bullish with 77% buy ratings and a $34.75 consensus target.
RSI shows promising revenue growth and institutional interest but faces valuation concerns with a high P/E of 81.13. The stock offers significant upside to analyst targets but requires careful monitoring of margin expansion and competitive pressures in the online gambling sector.
Trailing returns across standard periods
Latest headlines on both assets
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →